Thermo Fisher Scientific Inc said it would buy Binding Site Group from European private equity firm Nordic Capital in an all-cash transaction valued at 2.25 billion pounds ($2.6 billion), boosting its specialty diagnostics business.
https://www.pharmalive.com/wp-content/uploads/2022/10/ThermoFisher-researcher.jpeg500750Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-10-31 08:17:152022-10-31 11:20:34Thermo Fisher to buy diagnostics firm Binding Site for $2.6 billion
